Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.2478/acph-2018-0016

Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats

FUGEN GU ; Department of Pharmaceutics, Affiliated Hospital, Inner Mongolia Medical University, Hohhot 010050 China
JIA NING ; School of Pharmacy, Inner Mongolia Medical University, Hohhot 010110 China
HUIMIN FAN ; School of Pharmacy, Inner Mongolia Medical University, Hohhot 010110 China
CHUNZHI WU ; Department of Pharmaceutics, Affiliated Hospital, Inner Mongolia Medical University, Hohhot 010050 China
YI WANG ; Department of Pharmaceutics, Affiliated Hospital, Inner Mongolia Medical University, Hohhot 010050 China


Puni tekst: engleski pdf 582 Kb

str. 145-157

preuzimanja: 1.160

citiraj


Sažetak

Simvastatin is poorly bioavailable because it is practically insoluble in water and shows dissolution rate-limited absorption. Solubilizing effects of several β-cyclodextrin (βCD) derivatives such as HPβCD, SBEβCD and DMβCD on simvastatin in aqueous solution were investigated using the phase solubility technique. The solubility diagram of simvastatin with each βCD derivative could be classified as AL-type, indicating soluble complex formation of 1:1 stoichiometry. Among the above βCD derivatives DMβCD was found to be the ideal complexing agent for improving drug solubility. The simvastatin complex with DMβCD was prepared using the co-evaporation method and was then characterized by differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FT-IR) and in vitro dissolution. Dissolution and pharmacokinetic studies indicated that the simvastatin/DMβCD complex exhibited an increased dissolution rate, rapid absorption, and improved bioavailability in rats compared to free drug. Maximum plasma concentration (cmax) and the time to reach it (tmax) were 21.86 µg mL–1 and 1.4 h for the drug complex, 8.25 µg mL–1 and 3.0 h for free drug, respectively. Main pharmacokinetic parameters such as tmax, cmax were significantly different (p < 0.01) between the simvastatin complex and free drug. Bioavailability of the simvastatin complex relative to free drug was up to 167.0 %.

Ključne riječi

simvastatin; DMβCD; complex; solubility; dissolution rate; pharmacokinetics

Hrčak ID:

193566

URI

https://hrcak.srce.hr/193566

Datum izdavanja:

30.6.2018.

Posjeta: 2.149 *